GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » EBIT

NeuPath Health (TSXV:NPTH) EBIT : C$0.48 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health EBIT?

NeuPath Health's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was C$-0.03 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.48 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NeuPath Health's annualized ROC % for the quarter that ended in Sep. 2024 was 2.08%. NeuPath Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -1.34%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. NeuPath Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 2.45%.


NeuPath Health EBIT Historical Data

The historical data trend for NeuPath Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health EBIT Chart

NeuPath Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
-3.46 -3.39 -2.37 -3.25 0.98

NeuPath Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 -0.11 -0.05 0.67 -0.03

Competitive Comparison of NeuPath Health's EBIT

For the Medical Care Facilities subindustry, NeuPath Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeuPath Health's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NeuPath Health's EV-to-EBIT falls into.


;
;

NeuPath Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeuPath Health  (TSXV:NPTH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NeuPath Health's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=0.584 * ( 1 - -19.19% )/( (33.301 + 33.75)/ 2 )
=0.6960696/33.5255
=2.08 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

NeuPath Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.116/( ( (8.729 + max(-0.058999999999997, 0)) + (8.647 + max(-0.436, 0)) )/ 2 )
=-0.116/( ( 8.729 + 8.647 )/ 2 )
=-0.116/8.688
=-1.34 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.781 + 0 + 0.453) - (8.293 + 0 + 0)
=-0.058999999999997

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.443 + 0 + 0.596) - (8.475 + 0 + 0)
=-0.436

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

NeuPath Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=0.477/19.478
=2.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeuPath Health EBIT Related Terms

Thank you for viewing the detailed overview of NeuPath Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


NeuPath Health Business Description

Traded in Other Exchanges
N/A
Address
181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.
Executives
Joseph Andrew Walewicz Director
Daniel Chicoine Director
Daniel Marcel Legault Director
Grishanth Ram Ram Director
Grant Connelly Senior Officer
Stephen Lemieux Senior Officer

NeuPath Health Headlines

No Headlines